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Abstract
Introduction
It is estimated that 3.1 million women with a history of invasive 
breast cancer are living in the US with an additional 232,670 
newly diagnosed in 2014. Thirty-nine percent of these women 
received chemotherapy as part of their treatment plan. 
Chemotherapy used in breast cancer treatment causes anagen 
effluvium as it destroys the rapidly dividing cancer cells as well as 
the rapidly dividing hair matrix cells leading to abnormal 
anchoring or weakening. Hair loss from chemotherapy can begin 
within days to weeks following the start of treatment. By two 
months of treatment there is alopecia on the entire body, and hair 
loss continues for the entire duration of therapy. With the current 
standard of care for breast cancer using higher doses of 
chemotherapy the likelihood of certain, severe and sometimes 
permanent hair loss, means that more woman will be impacted by 
chemotherapy-induced alopecia.
Research Question
Literature Review
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Discussion
In summary, this review of studies found:
• Hair loss is consistently ranked among the most troublesome         
side effects of chemotherapy (Van den Hurk et al., 2012). 
Additional research found that many women felt losing their 
hair was more devastating than losing a breast, and that 8% of 
women in the study would refuse treatment due to the risk of 
alopecia (Yeager & Olsen, 2011). 
• Multiple studies including (Shin, 2014) and (Van den Hurk,                                                          
2009) have shown that scalp cooling is effective and currently 
the best method for preventing or reducing chemotherapy-
induced hair loss. With the recent FDA approval of cold cap 
therapy access to treatment should become more widely 
available.
• Hair reflects our individuality and is an indicator of a woman’s 
femininity, attractiveness and sexuality. For women diagnosed 
with breast cancer and impending chemotherapy treatment, the 
thought of CIA is overwhelmingly distressing. Patients who had 
high alopecia distress reported lower emotional, physical, 
cognitive and social functioning compared to patients (Choi et 
al., 2014).
• In conclusion, CIA can be devastating to women with breast 
cancer and effect their overall psychosocial well-being. In order 
to provide personalized care to patients - the multifaceted 
aspects of mental, emotional, social and spiritual health need to 
be addressed and, if necessary, treated. Treatments such a scalp 
cooling to prevent CIA should be viewed as of equal 
importance to disease management or cures. Additional studies 
on how to improve outcomes based on psychosocial well-being 
and improved long-term quality of life would be helpful in the 
treatment CIA as well as other medical conditions would be 
beneficial.
In women diagnosed with breast cancer that receive 
chemotherapy, does the use of cryotherapy in the prevention of 
alopecia provide the participants with increased positive 
physiological outcomes? 
The search of literature provided the following main points:  
• Chon, Champion, Geddes, & Rashid (2012) stated that across 
the literature hair loss due to chemotherapy is the most 
traumatic and burdensome aspect of treatment. (Figure 1).
• Shin, Jo, Kim, Kwon, & Myung (2014) reported scalp cooling 
method significantly reduced the development of CIA in 
comparison and reduced relative risk by one-third. (p<0.001). 
• This study should increase primary care providers awareness of 
the detrimental effects of CIA on their patients’ lives.
• The recent approval of cold cap therapy by the FDA will give 
patients more access to this treatment, allow for payment by 
insurance carriers and will become a standard of treatment for 
women with breast cancer in the prevention CIA. 
• CIA prevention  with scalp cryotherapy will minimize a 
devastating side-effect for patients and allow them to maintain 
their self-esteem, self-confidence and overall well-being. 
• A multidisciplinary approach to the management and care of 
breast cancer patients would make a physically, mentally, and 
emotionally devastating consequence of treatment into an 
opportunity for positive self-esteem. 
• The author would like to express her sincere appreciation to Dawn 
Hackman, Dr. Vicki McCleary and the millions of women that 
demonstrated the bravery and courage to endure breast cancer and its 
treatment to improve the care of women diagnosed in the future.
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Figure 1. Example of Chemotherapy-Induced Alopecia. 
Adapted from “Chemotherapy-induced Alopecia”, (Chon, et 
al., 2011), American Academy of Dermatology, e40. 
Copyright 2011 by the Academy of Dermatology.
In adult women with breast cancer, alopecia that often 
accompanies the use of chemotherapy can be devastating when 
added to the emotional distress of receiving treatment. 
According to the Up to Date database, cryotherapy is successful 
at reducing or preventing alopecia during breast cancer 
chemotherapy treatment. In addition, several recent studies have 
shown that chemotherapy-induced alopecia has a negative effect 
on the body image and psychological well-being of women with 
breast cancer. The review of literature from Cochrane and 
PubMed database, from the last ten years, explored studies of 
women ages 18-80 with breast cancer that evaluated the impact 
of chemotherapy-induced alopecia on patient’s self-confidence, 
body image, and well-being including anxiety and depression. 
Shin, Jo, Kim, Kwon, & Myung (2014) reported that scalp 
cooling method significantly reduced the development of CIA in 
comparison to other methods and reduced relative risk by one-
third. (p<0.001). Choi et al., (2014) found CIA distress was 
negatively associated with body image, psychosocial well-being 
and depression among breast cancer patients. Significant 
differences were found between the severity of alopecia and 
distress (p<0.001).This study found that CIA is a distressing 
side-effect of breast cancer treatment and that its prevention can 
minimize the psychological effects it has on a patient’s well-
being. Providers can improve the care of breast cancer patients 
that are receiving chemotherapy by offering scalp cryotherapy, 
as well as the information and resources necessary to reduce the 
psychological sequelae and improve their patients’ quality of 
life.
• Van den Hurk et al. (2009) examined efficacy scalp cooling has 
on well-being. Scalp cooling was successful 52% of the cases 
and the differences of well-being on scalp-cooled and non-scalp 
cooled patients was statistically significant (p<0.0001). Alopecia 
was the most distressing factor for all groups before 
chemotherapy and at three weeks and six months.
• Choi et al., (2014) found CIA distress was negatively associated 
with body image, psychosocial well-being and depression among 
breast cancer patients. Significant differences were found 
between the severity of alopecia and distress (p<0.001). 
• Begovic-Juhunt et al., (2012) found a significant relationship 
between body image and depression (p<0.01), overall quality of 
life (p<0.01), emotional well-being (p<0.05), and social well-
being (p<0.01).
Chemotherapy-induced alopecia is a crippling side-effect that 
negatively impacts the psychological and physiological well-being 
of women with breast cancer. With today’s health care focus being 
patient-centered, it is important that clinicians consider all aspects 
of care including a patient’s physical, mental and emotional well-
being.
